These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
83 related articles for article (PubMed ID: 7853673)
1. [Re-evaluation of current antimicrobials. Series 19: ceftriaxone. Discussion]. Jpn J Antibiot; 1994 Nov; 47(11):1433-40. PubMed ID: 7853673 [No Abstract] [Full Text] [Related]
2. [Re-evaluation of current antimicrobials. Series 20: netilmicin sulfate. Discussion]. Jpn J Antibiot; 1994 Nov; 47(11):1441-8. PubMed ID: 7853674 [No Abstract] [Full Text] [Related]
3. Influence of cephalosporines III generation with varying biliary excretion on fecal flora and emergence of resistant bacteria during and after cessation of therapy. Guggenbichler JP; Allerberger FJ; Dierich M Padiatr Padol; 1986; 21(4):335-42. PubMed ID: 3562044 [TBL] [Abstract][Full Text] [Related]
4. The efficacy of ceftriaxone in the treatment of severe infections in hospitalized patients. Alexopoulos E; Anassis P; Hadjidimitrou C; Papadimitriou M Chemioterapia; 1987 Jun; 6(2 Suppl):380-1. PubMed ID: 3509452 [No Abstract] [Full Text] [Related]
14. Indications for a ceftriaxone dosing regimen in Japanese paediatric patients using population pharmacokinetic/pharmacodynamic analysis and simulation. Iida S; Kawanishi T; Hayashi M J Pharm Pharmacol; 2011 Jan; 63(1):65-72. PubMed ID: 21155817 [TBL] [Abstract][Full Text] [Related]